Cutting edge: Extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength

被引:29
|
作者
Schade, AE
Levine, AD
机构
[1] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 172卷 / 10期
关键词
D O I
10.4049/jimmunol.172.10.5828
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Altered signaling through the TCR is currently showing promise for immunotherapy. However, the molecular mechanisms are not completely understood. Therefore, we investigated whether varying the strength of TCR engagement in various human T cells would yield different second messenger responses. The kinetics and duration of extracellular signal-regulated kinase (ERK) activation, central to multiple cellular responses, are distinctly dependent on the T cell activation state (naive vs effector), strength of TCR cross-linking, and input from the phosphatidylinositol-3 kinase pathway, which is regulated by cytokines and growth factors, Moreover, the duration of ERK activation affects c-Fos expression, a component of the AP-1 transcription complex. Thus, the character of ERK activation, transient or sustained, acts as a signal integrator to quantify the strength of TCR engagement and direct the cellular response.
引用
收藏
页码:5828 / 5832
页数:5
相关论文
共 50 条
  • [31] Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma
    de Melo, Merivane
    Gerbase, Margaret W.
    Curran, Joseph
    Pache, Jean-Claude
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2006, 54 (08) : 855 - 861
  • [32] Extracellular Signal-Regulated Kinases (ERK) Inhibitors from Aristolochia yunnanensis
    Cheng, Zhong-Bin
    Shao, Wei-Wei
    Liu, Ye-Na
    Liao, Qiong
    Lin, Ting-Ting
    Shen, Xiao-Yan
    Yin, Sheng
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (04): : 664 - 671
  • [33] The role of extracellular signal-regulated kinases in the neuroprotection of limb ischernic preconditioning
    Jin, Rui-Li
    Li, Wen-Bin
    Li, Qing-Jun
    Zhang, Min
    Man, Xiao-Hui
    Sun, Xiao-Cai
    Zhao, Hong-Gang
    Qi, Jie
    NEUROSCIENCE RESEARCH, 2006, 55 (01) : 65 - 73
  • [34] A ROLE FOR EXTRACELLULAR SIGNAL-REGULATED KINASES 1 AND 2 IN THE MAINTENANCE OF PERSISTENT MECHANICAL HYPERALGESIA IN OVARIECTOMIZED MICE
    Klinger, M. B.
    Sacks, S.
    Cervero, F.
    NEUROSCIENCE, 2011, 172 : 483 - 493
  • [35] Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinases 1/2 signaling.
    Du, Caigan
    Wang, Shuang
    Jiang, Jifu
    Guan, Qiunong
    Wang, Hao
    Nguan, Christopher Y.
    Jevnikar, Anthony M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 229 - 229
  • [36] Activation of the extracellular signal-regulated kinases 1 and 2 by adiponectin binding in HEK-293 cells
    Lee, MH
    Klein, RL
    Luttrell, LM
    DIABETES, 2005, 54 : A6 - A6
  • [37] Hyperoxia Disrupts Extracellular Signal-Regulated Kinases 1/2-Induced Angiogenesis in the Developing Lungs
    Menon, Renuka T.
    Shrestha, Amrit Kumar
    Barrios, Roberto
    Shivanna, Binoy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [38] Distribution of extracellular signal-regulated protein kinases 1 and 2 in the rat adrenal and their activation by angiotensin II
    McNeill, H
    Whitworth, E
    Vinson, GP
    Hinson, JP
    JOURNAL OF ENDOCRINOLOGY, 2005, 187 (01) : 149 - 157
  • [39] Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2
    Sauvant, C
    Holzinger, H
    Gekle, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01): : 234 - 241
  • [40] Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2
    Ahn, S
    Wei, HJ
    Garrison, TR
    Lefkowitz, RJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) : 7807 - 7811